JB

Mumbai, India Founded: 1976 • Age: 50 yrs Listed Acquired By Torrent Pharma
Generic drugs are manufactured by JB in Mumbai, India.

About JB

JB is a publicly listed company based in Mumbai (India) founded in 1976, and was acquired by Torrent Pharma in June 2025. Generic drugs are manufactured by JB in Mumbai, India. The company has 7,650 employees. Its chief executive, as recorded, is Nikhil Chopra. Its website jbpharma.com draws about 21 thousand monthly visits. Its Indian entity J B Chemicals And Pharmaceuticals Limited reported revenue of β‚Ή3,945 Cr. JB offers products and services including Pharmaceutical Formulations and Lozenges. Its focus areas include Traditional Pharmaceuticals.

Company details

JB was established in 1976 in Mumbai, India, within the pharmaceutical sector. Generic drugs are produced by the company, focusing on manufacturing operations. The headquarters are located in Mumbai, where core activities are managed. Nikhil Chopra is designated as CEO. The companys online presence is maintained through the domain jbpharma.com. Geographic focus remains centered in India for production and distribution.

  • Headquarters Mumbai, India
  • Employees 7,650
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website jbpharma.com
  • Social LinkedIn X Facebook
  • Acquired by Torrent Pharma (Jun 2025)
  • Legal Name Jb Chemicals & Pharmaceuticals Ltd.
Key Metrics
  • Annual Revenue
    ₹3,945 Cr

    FY 2026 · +6% YoY

  • Net Profit
    ₹709 Cr

    FY 2026 · 17% margin

  • EBITDA
    ₹1,140 Cr

    FY 2026 · 27% margin

  • Investors
    KKR

    & 1 more

  • Employee Count
    7,650
  • Acquired by
    Torrent Pharma

    & 1 more

    (Jun 2025)

Products & Services of JB

JB offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Lozenges.

Pharmaceutical Formulations
Healthcare Products

Formulations are manufactured across various therapeutic categories to meet global demands.

Lozenges
Specialty Products

Lozenges are developed and supplied for therapeutic purposes in multiple markets.

Investors in JB

JB has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR and Torrent Pharma.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by this private equity firm.
1976kkr.comNew York, United States
Formulations, APIs, drug discovery, marketing, and sales services are provided.
1959torrentpharma.comAhmedabad, India
Premium access

Investor details for JB

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of J B Chemicals And Pharmaceuticals Limited (JB)

J B Chemicals And Pharmaceuticals Limited is the primary company behind JB. The board of J B Chemicals And Pharmaceuticals Limited currently have 8 directors; the longest-serving is Sumit Bose, appointed in 2020. 48 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sumit Bose
DIN 03340616
Director31 Aug 20206 yrs 2 moJ B Chemicals And Pharmaceuticals Limited
Arun Duggal
DIN 00024262
Director05 Jul 20242 yrs 4 moJ B Chemicals And Pharmaceuticals Limited
Ashwani Kumar Puri
DIN 00160662
Director14 May 20251 yr 6 moJ B Chemicals And Pharmaceuticals Limited
Richa Arora
DIN 07144694
Director10 Jul 20251 yr 4 moJ B Chemicals And Pharmaceuticals Limited
Aman Samir Mehta
DIN 08174906
Managing Director21 Jan 20269 moJ B Chemicals And Pharmaceuticals Limited
Sudhir Menon
DIN 09502215
Director21 Jan 20269 moJ B Chemicals And Pharmaceuticals Limited
Amal Satyawan Kelshikar
DIN 06378987
Director21 Jan 20269 moJ B Chemicals And Pharmaceuticals Limited
Hasmukh Mathurbhai Patel
DIN 11486584
Director21 Jan 20269 moJ B Chemicals And Pharmaceuticals Limited

People of JB

48 people are tracked at JB (22 in leadership, 2 in board & advisors, 24 in team); the tracked headcount is 7,650.

NameRoleGroup
Nikhil Chopra
CEOLeadership
Kunal Khanna
President – OperationsLeadership
Manoj Chitnis
Vice President (corporate Quality Head)Leadership
Amit Nayak
Assistant Vice President, Commercial Excellence HeadLeadership
Issac Lazarus
General Manager MarketingLeadership
Ruchi Saboo-Tekle
Deputy General ManagerLeadership
Sandeep Nasa
Director – Russia, Ukraine & CIS Business (OOOUPL)Leadership
Suresh Bhise
Vice President – Information & TechnologyLeadership
Jason D’souza
Executive Vice PresidentLeadership
Pradeep Kumar Singh
President – Global BusinessLeadership
Sandeep Phadnis
Vice President – SecretarialLeadership
Parmeshwar Bang
Executive Vice President – Operations (Daman)Leadership
Sujay Rajhans
President – Research & DevelopmentLeadership
Sridhar Bharadwaj
Vice President – Human Resources & AdministrationLeadership
Anurag Agrawal
Vice President Regulatory AffairsLeadership
Bharatsinh Parmar
General Manager Human ResourcesLeadership
Kadir Idariya
Sr General Manager & Head-marketingLeadership
Vikrant Bendre
Head ROW (sales And Marketing)Leadership
Ajay Singh
Senior General Manager - Global BusinessLeadership
Dilip Singh Rathore
President – India BusinessLeadership

28 more people are available in the full profile.

Premium access

Complete people profiles for JB

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of JB

JB is a publicly listed company on the NSE with ticker symbol JBCHEPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Jul 2002
  • Listed onNSE: JBCHEPHARM
  • Listed entityJB Chemicals & Pharmaceuticals Ltd.
  • Exchange sectorHealth technology
  • ISININE572A01036
  • Share price₹2,209.20 (+2.76% on the day) · 2026-05-11
  • Market capitalisation₹34,551 Cr
  • Price to earnings46.6
  • EPS (diluted, trailing year)₹47.45
  • Dividend yield0.92%
  • Volume (last session)584,031
  • Analyst consensusBuy

Financials of JB

Figures of J B Chemicals And Pharmaceuticals Limited, the primary company behind JB, for FY 2026. Revenue was ₹3,945 Cr (+6% year on year). Net profit was ₹709 Cr (17% margin). EBITDA was ₹1,140 Cr (27% margin). Revenue has grown at a compounded annual rate of +10% over three years and +14% over five years.

  • ₹3,945 CrRevenue · FY 2026 · +6% YoY
  • ₹709 CrNet profit · 17% margin
  • ₹1,140 CrEBITDA · 27% margin
  • ₹16.06 CrPaid-up capital
  • 5,984Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2024₹3,892 Cr₹660 Cr₹1,017 Cr
2023₹3,468 Cr₹553 Cr₹893 Cr
2022₹3,130 Cr₹410 Cr₹699 Cr
2021₹2,403 Cr₹385 Cr₹533 Cr
2020₹2,003 Cr₹448 Cr₹524 Cr

Balance sheet, profit and loss, cash flow and ratios of J B Chemicals And Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for JB

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of JB

4 dated milestones of JB across 49 years, from founding to its latest funding, stage changes and deals.

  1. Founded JB is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Exit Acquired by KKR.
  4. Exit Acquired by Torrent Pharma.

Web traffic of JB

The website of JB (jbpharma.com) receives about 21.3K visits a month.

  • Monthly visits
    21.3K

    ▼ 35.5% vs previous month

Similar websites

Websites whose visitors overlap most with JB. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
torrentpharma.com
100%
31.6K#932,209View details
macleodspharma.com
98%
23.3K#522,868View details
aurobindo.com
98%
24.4K#1,029,164View details
glenmarkpharma.com
95%
106.3K#278,385View details
mangalamdrugs.com
75%
9.9K#1,747,627View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for JB

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as JB (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 72.52 M1,115
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jb

Premium access

Complete news archive for JB

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JB

JB was founded in 1976.

JB is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Nikhil Chopra is the CEO of JB, as recorded in our data.

JB has 7,650 employees.

The primary company behind JB, J B Chemicals And Pharmaceuticals Limited, reported revenue of β‚Ή3,945 Cr for FY 2026, up 6% year on year.

JB was established in 1976 in Mumbai, India, within the pharmaceutical sector. Generic drugs are produced by the company, focusing on manufacturing operations. The headquarters are located in Mumbai, where core activities are managed. Nikhil Chopra is designated as CEO. The companys online presence is maintained through the domain jbpharma.com. Geographic focus remains centered in India for production and distribution.

JB offers Pharmaceutical Formulations and Lozenges.

Yes, JB is publicly traded on NSE under the ticker symbol JBCHEPHARM.

JB has 2 investors. Key investors include KKR, and Torrent Pharma.

JB operates through J B Chemicals And Pharmaceuticals Limited.

Yes. JB was acquired by Torrent Pharma in June 2025.

The legal entities of JB currently have 10 directors, including Sandeep Anil Phadnis, Sumit Bose, Aman Samir Mehta and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available